Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination

被引：3

作者：

Bocchino, Marialuisa ^{[1
]}

Rea, Gaetano ^{[2
]}

Buonocore, Anna ^{[1
]}

Lieto, Roberta ^{[2
]}

Mazzocca, Annalisa ^{[1
]}

Di Domenico, Arcangela ^{[1
]}

Stanziola, Anna A. ^{[1
]}

机构：

[1] Univ Naples Federico II, Dept Clin Med & Surg, Resp Med Unit, Naples, Italy

[2] Monaldi Hosp, Dept Radiol, AO Colli, Naples, Italy

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2022年 / 38卷

关键词：

SARS-CoV-2 anti-COVID-19 mRNA vaccination; Acute exacerbation; Pulmonary embolism; Interstitial lung disease; FIBROSIS;

D O I：

10.1016/j.rmcr.2022.101674

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Coronavirus disease-2019 (COVID-19) is a systemic disorder with the lung and the vasculature being the preferred targets. Patients with interstitial lung diseases represent a category at high risk of progression in the case of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection, and as such deserve special attention. We first describe the combination of acute exacerbation and pulmonary embolism in an elderly ILD patient after booster anti-COVID-19 mRNA vaccination. Vaccines availability had significantly and safety impacted COVID-19 morbidity and mortality worldwide. Immunization against COVID-19 is indisputable but must not be separated from the awareness of potential adverse effects in fragile patients.

引用

页数：3